Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 9/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2785941 | 0.91 | PGR (0.47) | PGRNOS2PIK3CDTDP2 | |
| SCHEMBL2787876 | 0.88 | HDAC1 (0.35) | PGREPHX2PIK3CDPIM1PIM3 | |
| SCHEMBL2786310 | 0.87 | PGR (0.46) | PGRGRIN1GRIN2BPIK3CD | |
| SCHEMBL2785545 | 0.86 | PGR (0.46) | PGRGRIN1GRIN2BEPHX2PIK3CD | |
| SCHEMBL2785604 | 0.82 | PGR (0.50) | PGRGRIN1GRIN2BEPHX2PIK3CD | |
| SCHEMBL2785070 | 0.82 | PGR (0.46) | PGRPIK3CDTDP2 | |
| SCHEMBL3016234 | 0.75 | PGR (0.77) | PGREPHX2PIK3CD | |
| SCHEMBL3037435 | 0.75 | PGR (0.39) | PGRGRIN1GRIN2BNOS2 | |
| SCHEMBL2786464 | 0.73 | PGR (0.39) | PGRPIK3CDTDP2PIM1 | |
| SCHEMBL2785852 | 0.73 | PGR (0.41) | PGREPHX2PIK3CDTDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2209373-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-28 | — | — | EP | claimed |
| WO-2009045386-A1 | N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |